fda warning letters compounded tirzepatide 2024 2025 π¨ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Out of Shortage, Into Controversy:
Description
Tirzepatide Storage and Stability: A Comprehensive Review

Discuss any concerns with your healthcare provider to manage these side effects effectively

they can offer additional training or see if an alternative therapy exists

It does take a little time
